Please Wait...

Pulse Wave Analysis

In recent years, emphasis has been placed on the role of arterial stiffness in cardiovascular (CV) disease progression. Arterial stiffness is the major cause of heart attacks, heart failure, and stroke and the assessment of arterial stiffness is increasingly used for assessing CV risk and predicting CV outcomes. In contrast to systemic arterial stiffness, which can only be estimated from models of the circulation, regional and local arterial stiffness can be measured directly and noninvasively between various sites along the arterial tree.

Bioclinica offers a range of non-invasive clinic based and ambulatory central recording methodologies including:

  • Pulse wave analysis
  • Central aortic systolic pressure (CASP)
  • 24-hour central aortic systolic pressure (24-hour CASP)
  • Pulse wave velocity

ADDITIONAL RESOURCES

Collection and Analysis of BP data for Clinical Trials

Download WHITE PAPER

Ambulatory Blood Pressure Monitoring

Download DATA SHEET

Cardiovascular Imaging

Download DATA SHEET

Cardiac Safety Solutions

Download BROCHURE

Global Median Beat (GMB)

Download OVERVIEW SHEET

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is divided into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging and Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Biomarker Laboratory. Our eHealth segment comprises an eClinical Solutions Division along with Safety and Regulatory Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

NJ Statewide Career & Internship Fair is Friday, April 28! Talk w @BioclinicaJobs Proj Mgmt, BD, CDM, IT. Details… https://t.co/27LdT00OEo
bioclinica (5 hours ago)
eHealth Solutions president Mukhtar Ahmed is speaking at #Phorum17 on Apr. 27 https://t.co/OaBPodxZBF https://t.co/VO6GKV0a8v
bioclinica (6 hours ago)
Global Head of Risk-Based Monitoring Kristin Mauri on #RBM essential capabilities. Read the blog here https://t.co/z3yUGZqOzH
bioclinica (11 hours ago)
Guest column by Nancy Bradish Myers & Anne McNickle on the White House deregulatory landscape @MedDeviceOnline… https://t.co/LlCJtAPpWz
bioclinica (11 hours ago)
Kicking off day 2 Clinical Trial Innov. Summit! Patient recruitment, RBM, technology-enabled #ClinicaTrials r hot t… https://t.co/IoynV539R9
bioclinica (13 hours ago)
Join us in Philly nxt wk at #Biomarkers & Immuno #Oncology World Congress! Happy to answer Qs in any of these areas https://t.co/fJ5mVAfQTe
bioclinica (Yesterday)

Latest Blogs: